Literature DB >> 12115092

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

Katherine L O'Brien1, Bernard Beall, Nancy L Barrett, Paul R Cieslak, Arthur Reingold, Monica M Farley, Richard Danila, Elizabeth R Zell, Richard Facklam, Benjamin Schwartz, Anne Schuchat.   

Abstract

Severe invasive group A streptococcal (GAS) disease is believed to have reemerged during the past 10-20 years. We conducted active, laboratory, population-based surveillance in 5 US states (total population, 13,214,992). From 1 July 1995 through 31 December 1999, we identified 2002 episodes of invasive GAS (3.5 cases per 100,000 persons). Rates varied by age (higher among those <2 or >/=65 years old), surveillance area, and race (higher among black individuals) but did not increase during the study period. The 5 most common emm types (1, 28, 12, 3, and 11) accounted for 49.2% of isolates; newly characterized emm types accounted for 8.9% of isolates. Older age; presence of streptococcal toxic shock syndrome, meningitis, or pneumonia; and infection with emm1 or emm3 were all independent predictors of death. We estimate that 9600-9700 cases of invasive GAS disease occur in the United States each year, resulting in 1100-1300 deaths.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115092     DOI: 10.1086/341409

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  113 in total

1.  Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong.

Authors:  P L Ho; D R Johnson; A W Y Yue; D N C Tsang; T L Que; B Beall; E L Kaplan
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999.

Authors:  Gregory J Tyrrell; Marguerite Lovgren; Betty Forwick; Nancy P Hoe; James M Musser; James A Talbot
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

3.  Differential secretomics of Streptococcus pyogenes reveals a novel peroxide regulator (PerR)-regulated extracellular virulence factor mitogen factor 3 (MF3).

Authors:  Yao-Tseng Wen; Chih-Cheng Tsou; Hsin-Tzu Kuo; Jie-Siou Wang; Jiunn-Jong Wu; Pao-Chi Liao
Journal:  Mol Cell Proteomics       Date:  2011-06-02       Impact factor: 5.911

4.  Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus.

Authors:  Stephen B Beres; Ellen W Richter; Michal J Nagiec; Paul Sumby; Stephen F Porcella; Frank R DeLeo; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

5.  M protein gene type distribution among group A streptococcal clinical isolates recovered in Mexico City, Mexico, from 1991 to 2000, and Durango, Mexico, from 1998 to 1999: overlap with type distribution within the United States.

Authors:  Luz Elena Espinosa; Zhongya Li; Demostenes Gomez Barreto; Ernesto Calderon Jaimes; Romeo S Rodriguez; Varja Sakota; Richard R Facklam; Bernard Beall
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

6.  emm typing of M nontypeable invasive group A streptococcal isolates in Israel.

Authors:  Allon E Moses; Carlos Hidalgo-Grass; Mary Dan-Goor; Joseph Jaffe; Ilanit Shetzigovsky; Miriam Ravins; Zinaida Korenman; Ronit Cohen-Poradosu; Ran Nir-Paz
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

7.  Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics.

Authors:  Liliana Mihaila-Amrouche; Anne Bouvet; Julien Loubinoux
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues.

Authors:  Carlos Hidalgo-Grass; Inbal Mishalian; Mary Dan-Goor; Ilia Belotserkovsky; Yoni Eran; Victor Nizet; Amnon Peled; Emanuel Hanski
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

9.  SalY of the Streptococcus pyogenes lantibiotic locus is required for full virulence and intracellular survival in macrophages.

Authors:  Hilary A Phelps; Melody N Neely
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

10.  Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever.

Authors:  S Le Hello; A Doloy; F Baumann; N Roques; P Coudene; B Rouchon; F Lacassin; A Bouvet
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.